HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Maeda Selected Research

Norepinephrine (Noradrenaline)

12/2001Reduction of cardiac norepinephrine improves postischemic heart function in stroke-prone spontaneously hypertensive rats.
2/2001Effects of a dual L/N-type Ca(2+) channel blocker cilnidipine on neurally mediated chronotropic response in anesthetized dogs.
9/2000Impaired heart function and noradrenaline release after ischaemia in stroke-prone spontaneously hypertensive rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Maeda Research Topics

Disease

22Neoplasms (Cancer)
01/2019 - 03/2000
12Infections
02/2012 - 04/2000
11Heart Failure
01/2019 - 03/2000
9Neoplasm Metastasis (Metastasis)
01/2014 - 03/2000
9Carcinoma (Carcinomatosis)
05/2010 - 09/2000
6Myocardial Infarction
09/2014 - 08/2000
6Fibrosis (Cirrhosis)
07/2010 - 07/2000
6Inflammation (Inflammations)
12/2005 - 06/2001
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2008 - 01/2000
5Schizophrenia (Dementia Praecox)
08/2006 - 05/2000
5Ischemia
10/2001 - 02/2000
5Coronary Artery Disease (Coronary Atherosclerosis)
07/2001 - 03/2000
4Colorectal Neoplasms (Colorectal Cancer)
01/2006 - 04/2000
4Stomach Neoplasms (Stomach Cancer)
12/2005 - 03/2000
3Rectal Neoplasms (Rectal Cancer)
01/2016 - 04/2002
3Breast Neoplasms (Breast Cancer)
07/2013 - 06/2000
3Prolapse
04/2012 - 07/2003
3Periodontitis
01/2011 - 04/2008
3Atherosclerosis
05/2006 - 07/2000
3Stroke (Strokes)
12/2001 - 09/2000
3Ventricular Remodeling
11/2001 - 04/2001
3Glomerulonephritis
11/2001 - 04/2000
3Infarction (Infarctions)
06/2001 - 02/2000
2Ulcerative Colitis
02/2011 - 03/2000
2Chronic Kidney Failure (Chronic Renal Failure)
01/2009 - 05/2001
2Abscess
06/2007 - 08/2001
2Lymphatic Metastasis
01/2006 - 01/2001
2Hernia (Hernias)
11/2005 - 09/2003
2Liver Diseases (Liver Disease)
07/2004 - 10/2001
2Necrosis
02/2004 - 03/2000
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2002 - 11/2001
2Respiratory Tract Infections (Respiratory Tract Infection)
12/2001 - 10/2001
2Body Weight (Weight, Body)
12/2001 - 10/2001
2Periapical Periodontitis (Apical Periodontitis)
10/2001 - 06/2001
2Obesity
07/2001 - 09/2000
2Colonic Neoplasms (Colon Cancer)
07/2001 - 08/2000
2Left Ventricular Dysfunction
06/2001 - 03/2000
2Hypertrophy
04/2001 - 10/2000
2IGA Glomerulonephritis (IGA Nephropathy)
03/2001 - 04/2000
2Atrial Fibrillation
10/2000 - 07/2000
1Deglutition Disorders (Dysphagia)
01/2021
1Dyspnea (Shortness of Breath)
01/2021

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
07/2014 - 02/2000
7Biomarkers (Surrogate Marker)IBA
04/2013 - 03/2000
7CytokinesIBA
04/2010 - 11/2000
6Peptides (Polypeptides)IBA
07/2014 - 04/2000
6DNA (Deoxyribonucleic Acid)IBA
08/2011 - 02/2000
5InterferonsIBA
07/2010 - 11/2001
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2008 - 04/2000
5EnzymesIBA
03/2002 - 03/2000
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2001 - 03/2000
5Atrial Natriuretic Factor (ANF)IBA
06/2001 - 07/2000
5Brain Natriuretic Peptide (Natrecor)FDA Link
04/2001 - 07/2000
4Indicators and Reagents (Reagents)IBA
01/2021 - 09/2000
4AntibodiesIBA
06/2012 - 02/2000
4Chemokine ReceptorsIBA
02/2011 - 10/2001
4Interleukin-6 (Interleukin 6)IBA
12/2001 - 03/2000
4Clarithromycin (Biaxin)FDA LinkGeneric
12/2001 - 01/2000
4Glycoproteins (Glycoprotein)IBA
10/2001 - 07/2000
3Adenosine Triphosphate (ATP)IBA
07/2014 - 02/2000
3AntigensIBA
04/2013 - 01/2001
3AdiponectinIBA
04/2010 - 06/2000
3Natriuretic PeptidesIBA
12/2001 - 07/2000
3Norepinephrine (Noradrenaline)FDA LinkGeneric
12/2001 - 09/2000
3AldosteroneIBA
11/2001 - 09/2000
3procollagen Type III-N-terminal peptide (PIIP)IBA
11/2001 - 09/2000
3OsteopontinIBA
10/2001 - 01/2001
3von Willebrand FactorIBA
07/2001 - 04/2000
3Collagen Type III (Type III Collagen)IBA
04/2001 - 09/2000
2AnionsIBA
07/2014 - 07/2013
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2013 - 06/2001
2Shiga Toxin (Shigella Toxin)IBA
02/2012 - 03/2008
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2008 - 05/2001
2Gingipain Cysteine EndopeptidasesIBA
06/2007 - 08/2001
2N-Methylaspartate (NMDA)IBA
02/2006 - 08/2000
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2005 - 10/2000
2Monoclonal AntibodiesIBA
02/2004 - 02/2000
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
02/2004 - 03/2000
2Immunoglobulin G (IgG)IBA
01/2004 - 11/2001
2Endothelin-1 (Endothelin 1)IBA
02/2003 - 09/2000
2MacrolidesIBA
12/2001 - 10/2001
2Phosphatidylinositols (Phosphatidylinositol)IBA
11/2001 - 05/2001
2CollagenIBA
11/2001 - 07/2001
2Biological ProductsIBA
08/2001 - 01/2000
2Thrombospondin 1IBA
07/2001 - 04/2000
2ImmunosorbentsIBA
06/2001 - 07/2000
2Spironolactone (Aldactone)FDA LinkGeneric
04/2001 - 09/2000
2Immunoglobulin A (IgA)IBA
03/2001 - 04/2000
2Proliferating Cell Nuclear Antigen (PCNA)IBA
09/2000 - 05/2000

Therapy/Procedure

13Therapeutics
01/2019 - 03/2000
4Drug Therapy (Chemotherapy)
12/2011 - 09/2000
3Activities of Daily Living (ADL)
01/2021 - 03/2000
3Lymph Node Excision (Lymph Node Dissection)
10/2006 - 01/2001
3Radiotherapy
12/2001 - 02/2000
2Laparotomy
04/2012 - 03/2004
2Colostomy
04/2012 - 03/2004
2Gastrectomy
12/2005 - 01/2001
2Renal Dialysis (Hemodialysis)
09/2003 - 06/2000
2Sutures (Suture)
09/2003 - 07/2003
2Electric Countershock (Cardioversion)
10/2000 - 07/2000